MetLife Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
5,584
+123
| +2% | +$4.47K | ﹤0.01% | 2182 |
|
|
2025
Q1 | $198K | Sell |
5,461
-12
| -0.2% | -$435 | ﹤0.01% | 2210 |
|
|
2024
Q4 | $230K | Sell |
5,473
-208
| -4% | -$8.75K | ﹤0.01% | 2234 |
|
|
2024
Q3 | $316K | Buy |
5,681
+73
| +1% | +$4.06K | ﹤0.01% | 2038 |
|
|
2024
Q2 | $230K | Buy |
5,608
+829
| +17% | +$34.1K | ﹤0.01% | 2156 |
|
|
2024
Q1 | $223K | Buy |
4,779
+15
| +0.3% | +$700 | ﹤0.01% | 2143 |
|
|
2023
Q4 | $228K | Buy |
4,764
+608
| +15% | +$29.1K | ﹤0.01% | 2166 |
|
|
2023
Q3 | $148K | Buy |
4,156
+2
| +0% | +$71 | ﹤0.01% | 2370 |
|
|
2023
Q2 | $192K | Buy |
4,154
+698
| +20% | +$32.2K | ﹤0.01% | 2300 |
|
|
2023
Q1 | $139K | Buy |
3,456
+8
| +0.2% | +$321 | ﹤0.01% | 2419 |
|
|
2022
Q4 | $160K | Sell |
3,448
-82
| -2% | -$3.8K | ﹤0.01% | 2384 |
|
|
2022
Q3 | $146K | Sell |
3,530
-4
| -0.1% | -$166 | ﹤0.01% | 2475 |
|
|
2022
Q2 | $211K | Buy |
3,534
+67
| +2% | +$4K | ﹤0.01% | 2286 |
|
|
2022
Q1 | $252K | Buy |
+3,467
| New | +$252K | ﹤0.01% | 2213 |
|
|
2021
Q2 | – | Sell |
-23,550
| Closed | -$2.68M | – | 2479 |
|
|
2021
Q1 | $2.68M | Sell |
23,550
-1,332
| -5% | -$152K | 0.02% | 732 |
|
|
2020
Q4 | $3.44M | Buy |
24,882
+994
| +4% | +$138K | 0.03% | 556 |
|
|
2020
Q3 | $1.96M | Sell |
23,888
-1,069
| -4% | -$87.9K | 0.02% | 731 |
|
|
2020
Q2 | $1.95M | Buy |
24,957
+2,102
| +9% | +$164K | 0.02% | 724 |
|
|
2020
Q1 | $1.02M | Sell |
22,855
-1,607
| -7% | -$71.4K | 0.01% | 896 |
|
|
2019
Q4 | $1.04M | Hold |
24,462
| – | – | 0.01% | 1082 |
|
|
2019
Q3 | $1.05M | Hold |
24,462
| – | – | 0.01% | 1043 |
|
|
2019
Q2 | $1.55M | Buy |
24,462
+2,166
| +10% | +$138K | 0.02% | 921 |
|
|
2019
Q1 | $1.55M | Buy |
22,296
+2,069
| +10% | +$144K | 0.02% | 916 |
|
|
2018
Q4 | $879K | Hold |
20,227
| – | – | 0.01% | 1071 |
|
|
2018
Q3 | $1.54M | Sell |
20,227
-1,278
| -6% | -$97.6K | 0.02% | 959 |
|
|
2018
Q2 | $1.65M | Buy |
21,505
+1,383
| +7% | +$106K | 0.02% | 853 |
|
|
2018
Q1 | $1.03M | Buy |
20,122
+1,807
| +10% | +$92.1K | 0.01% | 995 |
|
|
2017
Q4 | $849K | Buy |
+18,315
| New | +$849K | 0.01% | 1099 |
|